Tumor Infiltrating Lymphocytes Signature as a New Pan-Cancer Predictive Biomarker of Anti PD-1/PD-L1 Efficacy

Tumor immune infiltrates are associated with tumor prognosis in many cancer types. However, their capacity to predict the efficacy of checkpoint inhibitors is poorly documented. We generate three signatures that evaluate in different ways these infiltrates: lymphoid- and myeloid-alone signatures, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballot, Elise, Ladoire, Sylvain, Routy, Bertrand, Truntzer, Caroline, Ghiringhelli, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564481/
https://www.ncbi.nlm.nih.gov/pubmed/32858956
http://dx.doi.org/10.3390/cancers12092418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564481/
https://www.ncbi.nlm.nih.gov/pubmed/32858956
http://dx.doi.org/10.3390/cancers12092418

Ejemplares similares